NCT06651359 Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
| NCT ID | NCT06651359 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Prostate Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 248 participants |
| Start Date | 2025-08-24 |
| Primary Completion | 2029-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 248 participants in total. It began in 2025-08-24 with a primary completion date of 2029-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in examining their quality of life.
Eligibility Criteria
Inclusion Criteria: \- Ethnically-diverse Black prostate cancer (CaP) survivors who are either native-born, Caribbean-born, or African-born Exclusion Criteria: * Men from other races. * Men who have never been diagnosed with CaP * Men who have the inability to speak English
Contact & Investigator
Motolani Adedipe, PhD, DPh, MS
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT06651359 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06651359 currently recruiting?
Yes, NCT06651359 is actively recruiting participants. Contact the research team at Motolani-adedipe@ouhsc.edu for enrollment information.
Where is the NCT06651359 trial being conducted?
This trial is being conducted at Tallahassee, United States, Milledgeville, United States, Oklahoma City, United States.
Who is sponsoring the NCT06651359 clinical trial?
NCT06651359 is sponsored by University of Oklahoma. The principal investigator is Motolani Adedipe, PhD, DPh, MS at University of Oklahoma. The trial plans to enroll 248 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.